American Century entities and the Stowers Institute reported significant passive ownership in Civeo Corporation common stock. American Century Investment Management, Inc., American Century Companies, Inc., and the Stowers Institute for Medical Research each reported beneficial ownership of 640,269 shares, representing 5.8% of the common stock, with sole voting and dispositive power and no shared power. American Century ETF Trust reported beneficial ownership of 615,126 shares, or 5.6%, also with sole voting and dispositive power.
The filing explains that various investment companies and institutional accounts advised by American Century Investment Management have rights to dividends and sale proceeds, but no single client holds more than 5% of the class. American Century Investment Management is a wholly owned subsidiary of American Century Companies, which is controlled by the Stowers Institute for Medical Research, and the parties agreed to a joint filing regarding this beneficial ownership.
Shares beneficially owned (ACIM/ACC/Stowers)640,269 sharesBeneficial ownership of Civeo common stock with sole voting and dispositive power; 5.8% of class
Ownership percentage (ACIM/ACC/Stowers)5.8%Percent of Civeo common stock class reported as beneficially owned
Shares beneficially owned (ETF Trust)615,126 sharesAmerican Century ETF Trust beneficial ownership of Civeo common stock; sole voting and dispositive power
Ownership percentage (ETF Trust)5.6%Percent of Civeo common stock class held by American Century ETF Trust
Key Terms
beneficial owner, sole voting power, sole dispositive power, Investment Advisers Act of 1940
4 terms
beneficial ownerfinancial
"that is a beneficial owner of securities that are subject of this schedule"
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
sole voting powerfinancial
"5 | Sole Voting Power 615,126.00 6 | Shared Voting Power 0.00"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
sole dispositive powerfinancial
"7 | Sole Dispositive Power 640,269.00 8 | Shared Dispositive Power 0.00"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
Investment Advisers Act of 1940regulatory
"an investment adviser registered under Section 203 of the Investment Advisers Act of 1940"
A U.S. federal law that sets rules for people and firms who give investment advice, requiring them to register with regulators, be honest about conflicts, keep records, and follow basic standards of care. It matters to investors because those rules act like licensing and consumer protections — similar to having safety standards for a mechanic — helping ensure advisers act in clients’ financial interests and reducing the risk of fraud or misuse of funds.
FAQ
What ownership stake in Civeo Corporation (CVEO) did American Century report?
The filing reports that 640,269 shares of Civeo common stock, representing 5.8% of the class, are beneficially owned by American Century Investment Management, American Century Companies, and the Stowers Institute, each with sole voting and dispositive power.
How many Civeo (CVEO) shares does American Century ETF Trust hold?
American Century ETF Trust reported beneficial ownership of 615,126 Civeo common shares, representing 5.6% of the class, with sole power to vote and sole power to dispose of those shares, and no shared voting or dispositive power.
Do American Century entities share voting power over Civeo (CVEO) shares?
The reporting entities disclose sole voting power and sole dispositive power over their Civeo shares, with 0 shared voting and 0 shared dispositive power, indicating control over voting and disposition is not shared with other parties.
Who ultimately controls the American Century entities holding Civeo (CVEO) stock?
The filing states that American Century Investment Management, Inc. is a wholly owned subsidiary of American Century Companies, Inc., which is controlled by the Stowers Institute for Medical Research, and these entities jointly report beneficial ownership of the Civeo shares.
Do American Century’s advisory clients individually own more than 5% of Civeo (CVEO)?
No single client advised by American Century Investment Management, Inc. owns more than 5% of Civeo’s common stock. The filing notes that various funds and institutional accounts have dividend and sale-proceed rights, but each client’s interest is below the 5% threshold.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)
Civeo Corporation
(Name of Issuer)
Common Stock
(Title of Class of Securities)
17878Y207
(CUSIP Number)
06/30/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
17878Y207
1
Names of Reporting Persons
American Century ETF Trust
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
615,126.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
615,126.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
615,126.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.6 %
12
Type of Reporting Person (See Instructions)
IV
SCHEDULE 13G
CUSIP Number(s):
17878Y207
1
Names of Reporting Persons
American Century Investment Management, Inc.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
640,269.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
640,269.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
640,269.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.8 %
12
Type of Reporting Person (See Instructions)
IA
SCHEDULE 13G
CUSIP Number(s):
17878Y207
1
Names of Reporting Persons
American Century Companies, Inc.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
640,269.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
640,269.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
640,269.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.8 %
12
Type of Reporting Person (See Instructions)
HC
SCHEDULE 13G
CUSIP Number(s):
17878Y207
1
Names of Reporting Persons
Stowers Institute for Medical Research
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
640,269.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
640,269.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
640,269.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.8 %
12
Type of Reporting Person (See Instructions)
HC
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Civeo Corporation
(b)
Address of issuer's principal executive offices:
Three Allen Center, 333 Clay Street, Suite 4400, Houston, Texas, 77002
Item 2.
(a)
Name of person filing:
American Century ETF Trust
American Century Investment Management, Inc.
American Century Companies, Inc.
Stowers Institute for Medical Research
(b)
Address or principal business office or, if none, residence:
4500 Main Street
9th Floor
Kansas City, Missouri 64111
(c)
Citizenship:
Delaware
(d)
Title of class of securities:
Common Stock
(e)
CUSIP No.:
17878Y207
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
See the response(s) to Item 9 on the attached cover page(s).
(b)
Percent of class:
See the response(s) to Item 11 on the attached cover page(s).
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
See the response(s) to Item 5 on the attached cover page(s).
(ii) Shared power to vote or to direct the vote:
See the response(s) to Item 6 on the attached cover page(s).
(iii) Sole power to dispose or to direct the disposition of:
See the response(s) to Item 7 on the attached cover page(s).
(iv) Shared power to dispose or to direct the disposition of:
See the response(s) to Item 8 on the attached cover page(s).
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
Various persons, including the investment companies and separate institutional investor accounts that American Century Investment Management, Inc. ("ACIM") serves as investment adviser, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities that are the subject of this schedule. Except as may be otherwise indicated if this is a joint filing, not more than 5% of the class of securities that is the subject of this schedule is owned by any one client advised by ACIM.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
This Item identifies each subsidiary of American Century Companies, Inc. ("ACC"), which is controlled by the Stowers Institute for Medical Research, that is a beneficial owner of securities that are subject of this schedule (the "Subject Securities"). American Century Investment Management, Inc. ("ACIM") is a wholly-owned subsidiary of ACC and an investment adviser registered under Section 203 of the Investment Advisers Act of 1940.
Item 8.
Identification and Classification of Members of the Group.
If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group.
Not applicable
Item 9.
Notice of Dissolution of Group.
Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity. See Item 5.
Not applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
American Century ETF Trust
Signature:
American Century ETF Trust
Name/Title:
/s/ John Pak / Senior Vice President
Date:
08/14/2026
American Century Investment Management, Inc.
Signature:
American Century Investment Management, Inc.
Name/Title:
/s/ John Pak / Senior Vice President
Date:
08/14/2026
American Century Companies, Inc.
Signature:
American Century Companies, Inc.
Name/Title:
/s/ John Pak / Senior Vice President
Date:
08/14/2026
Stowers Institute for Medical Research
Signature:
Stowers Institute for Medical Research
Name/Title:
/s/ Joselyn Verschelden / Authorized Signer
Date:
08/14/2026
Exhibit Information
EXHIBIT
Each of the undersigned hereby agrees and consents to the execution and joint filing on its behalf by American Century Investment Management, Inc. of this Schedule 13G respecting the beneficial ownership of the securities which are the subject of this schedule.
Dated this 14th day of August, 2026.
AMERICAN CENTURY ETF TRUST ("ACETF")
AMERICAN CENTURY INVESTMENT MANAGEMENT, INC. ("ACIM")
AMERICAN CENTURY COMPANIES, INC. ("ACC")
By: __/s/ John Pak___________________
John Pak
Senior Vice President, ACETF, ACIM and ACC
STOWERS INSTITUTE FOR MEDICAL RESEARCH, solely in its capacity as control entity of ACC
By: __/s/ Joselyn Verschelden_________
Joselyn Verschelden
Authorized Signer
